CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis

Rationale: Cystic fibrosis (CF), caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, leads to impaired pancreatic function and therefore reduced intestinal absorption of lipids and fat-soluble vitamins especially in patients with CF developing pancreatic insuf...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerburg, Olaf, Hämmerling, Susanne, Schneider, S. Philipp, Okun, Jürgen, Langhans, Claus-Dieter, Leutz-Schmidt, Patricia, Wielpütz, Mark O., Siems, Werner, Gräber, Simon Y., Mall, Marcus A., Stahl, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003491/
https://www.ncbi.nlm.nih.gov/pubmed/33808590
http://dx.doi.org/10.3390/antiox10030483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003491/
https://www.ncbi.nlm.nih.gov/pubmed/33808590
http://dx.doi.org/10.3390/antiox10030483

Ejemplares similares